tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

ResMed Inc. Announces Stock Transaction by Global General Counsel

Story Highlights
ResMed Inc. Announces Stock Transaction by Global General Counsel

Elevate Your Investing Strategy:

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.

ResMed Inc., a company involved in the healthcare industry, focuses on the development and manufacturing of equipment related to sleep disorders and respiratory care. The recent filing indicates a transaction involving the sale of common stock by Michael J. Rider, Global General Counsel and Secretary, under a pre-established Rule 10b5-1 plan. This transaction reflects changes in beneficial ownership and may have implications for the company’s stock market activities.

The most recent analyst rating on (AU:RMD) stock is a Buy with a A$37.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.

More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

Average Trading Volume: 1,168,424

Technical Sentiment Signal: Buy

Current Market Cap: A$57.14B

See more insights into RMD stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1